QRG CAPITAL MANAGEMENT, INC.

Position in GILD — Gilead Sciences, Inc.

CIK 1996454 BERWYN, PA

Position in GILD

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$28,745,255

-$2,786,650 QoQ

Shares Held

227,523

+0.6% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.26%

of 13F equity value

Holder Rank

#279

of 2,266 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

QRG CAPITAL MANAGEMENT, INC. holds $606,823,434 across 15 Drug Manufacturers - General names. GILD ranks #6 (4.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	146,305	$175,482,620
2	JNJ	Johnson & Johnson	440,815	$111,953,785
3	ABBV	AbbVie Inc.	301,006	$75,745,149
4	MRK	Merck & Co., Inc.	428,993	$55,125,600
5	AMGN	Amgen Inc	98,650	$35,723,138
6	GILD	Gilead Sciences, Inc. This page	227,523	$28,745,255
7	NVS	Novartis AG	164,478	$25,776,992
8	PFE	Pfizer Inc	902,308	$21,727,576

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$28,745,255	227,523	+0.6%	Shares	Sole	2026-07-14
2026-03-31	$31,531,905	226,246	-6.3%	Shares	Sole	2026-04-27
2025-12-31	$29,627,594	241,385	+6.2%	Shares	Sole	2026-02-02
2025-09-30	$25,224,972	227,252	-24.1%	Shares	Sole	2025-10-28
2025-06-30	$33,215,210	299,587	+6.9%	Shares	Sole	2025-07-21
2025-03-31	$31,408,735	280,310	+8.4%	Shares	Sole	2025-04-17
2024-12-31	$23,885,496	258,585	+7.1%	Shares	Sole	2025-02-05
2024-09-30	$20,242,664	241,444	-4.7%	Shares	Sole	2024-10-30
2024-06-30	$17,379,530	253,309	-33.2%	Shares	Sole	2024-07-12
2024-03-31	$27,782,186	379,279	-5.6%	Shares	Sole	2024-05-07
2023-12-31	$32,563,751	401,972	+33.3%	Shares	Sole	2024-02-07
2023-09-30	$22,593,061	301,482	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.